PAR 16.2% 57.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Phase 2 Clinical Trial, page-41

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5 Posts.
    so given the impact of the announcements today, does anyone have any theories what the share price will do going forward? after the impact of the first trial results, anticipation was high and thus increased the SP, however after the results the SP was slashed by 2/3, now given the 2nd results have been released are we going to see a similar course of events occur?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
57.5¢
Change
0.080(16.2%)
Mkt cap ! $82.30M
Open High Low Value Volume
50.5¢ 58.0¢ 50.0¢ $753.7K 1.388M

Buyers (Bids)

No. Vol. Price($)
2 3168 57.0¢
 

Sellers (Offers)

Price($) Vol. No.
57.5¢ 102000 2
View Market Depth
Last trade - 12.31pm 04/12/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.